IPO雷达|九年估值升45倍,麦济生物赴港上市胜算几何?

界面
24 Jul

日前,湖南麦济生物技术股份有限公司(下称“麦济生物”)向港交所主板递交上市申请,中金公司担任独家保荐人。这家成立于2016年的创新生物药企由张成海博士及其外甥女李敏共同创立,目前仅有43名员工。八年间,公司围绕过敏性及自身免疫疾病打造出8款抗体候选药管线,其中核心产品MG-K10已推进至注册性III期临床。然而截至2024年底,麦济生物尚无自主产品收入,过去两年累计研发投入达3.16亿元人民币,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10